https://www.selleckchem.com/pr....oducts/ldc203974-imt
8%). Age, stage of cancer, presence of infection, type of cancer, and type of treatment had shown a significant association with fatigue [AOR = 3.15, 95% CI (1.35-7.34)], [AOR = 0.02, 95% CI (0.003-0.172)], [AOR = 4.15, 95% CI (1.06-16.07)], [AOR = 5.19, 95% CI (1.59-16.9], [AOR = 0.18, 95% CI (0.07-0.462)] respectively. The prevalence of fatigue in cancer patients in this study was high. Risk factors were age of the patients, stage of cancer, presence of infection, cervical cancer and radiation therapy. The prevalence of fati
Like
Comment
Share
